{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04385082",
            "orgStudyIdInfo": {
                "id": "19-000876"
            },
            "secondaryIdInfos": [
                {
                    "id": "R01DA047296",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R01DA047296"
                }
            ],
            "organization": {
                "fullName": "University of California, Los Angeles",
                "class": "OTHER"
            },
            "briefTitle": "Cannabis Effects as a Function of Sex (CanSex)",
            "officialTitle": "Sex-dependent Effects of Cannabis: Assessing Analgesic, Abuse-related and Pharmacokinetic Differences Between Men and Women",
            "acronym": "CanSex",
            "therapeuticArea": [
                "Other"
            ],
            "study": "cannabis-effects-as-a-function-of-sex-cansex"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-07-08",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-06-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-06-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-05-07",
            "studyFirstSubmitQcDate": "2020-05-11",
            "studyFirstPostDateStruct": {
                "date": "2020-05-12",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-15",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-16",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Ziva D. Cooper, PhD",
                "investigatorTitle": "Associate Professor",
                "investigatorAffiliation": "University of California, Los Angeles"
            },
            "leadSponsor": {
                "name": "University of California, Los Angeles",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute on Drug Abuse (NIDA)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this research is to assess the impact of cannabis on the analgesic and abuse-related effects between men and women",
            "detailedDescription": "The proposed study will compare smoked cannabis's dose-dependent, analgesic and abuse-related effects between men and women and variables that underlie these sex-dependent differences, including pharmacokinetics of THC."
        },
        "conditionsModule": {
            "conditions": [
                "Pain",
                "Abuse, Drug"
            ],
            "keywords": [
                "Pain",
                "Cannabis",
                "THC"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "interventionModelDescription": "This is a randomized, double-blind, placebo-controlled study. All participants will complete all dose conditions in a randomized order.",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 160,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Smoked Cannabis (\\~0% THC)",
                    "interventionNames": [
                        "Drug: Placebo Cannabis"
                    ]
                },
                {
                    "label": "Low strength cannabis",
                    "type": "EXPERIMENTAL",
                    "description": "Smoked Cannabis (\\~4% THC)",
                    "interventionNames": [
                        "Drug: Active Cannabis"
                    ]
                },
                {
                    "label": "Higher strength cannabis",
                    "type": "EXPERIMENTAL",
                    "description": "Smoked Cannabis (\\~10% THC)",
                    "interventionNames": [
                        "Drug: Active Cannabis"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Active Cannabis",
                    "description": "Smoked cannabis with THC",
                    "armGroupLabels": [
                        "Higher strength cannabis",
                        "Low strength cannabis"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo Cannabis",
                    "description": "Placebo smoked cannabis (no THC)",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Subject-rated drug effects",
                    "description": "Average and peak subjective ratings of drug effects associated with abuse liability as measured using visual analogue scales (VAS; 1-100mm).",
                    "timeFrame": "5 hours"
                },
                {
                    "measure": "Analgesia as measured using the Cold Pressor Test",
                    "description": "Peak and average pain threshold and tolerance assessed using the Cold Pressor Test",
                    "timeFrame": "5 hours"
                },
                {
                    "measure": "Pharmacokinetics of THC and metabolites",
                    "description": "Plasma levels of THC, 11-OH-THC, and THCCOOH",
                    "timeFrame": "5 hours"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Drug reinforcement using the cannabis self-administration task",
                    "description": "Average number of cannabis puffs self-administered as a function of cannabis strength and sex. For this task, up to three 'puffs' of cannabis may be chosen for self-administration during each session.",
                    "timeFrame": "5 hours"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or non-pregnant female aged 21-55 years\n* Report use of cannabis an average of 1-7 days per week\n* Not currently seeking treatment for their cannabis use\n* Urine test positive for recent cannabis use for heavy users\n* No reported adverse effects with cannabis smoking in light users\n* Have a Body Mass Index from 18.5 - 34kg/m2.\n* Able to perform all study procedures\n* FEMALES: Currently practicing a non-hormonal effective form of birth control\n* FEMALES: Must be regularly cycling\n\nExclusion Criteria:\n\n* Meeting DSM-V criteria for any substance use disorder other than nicotine, caffeine, or cannabis use disorder\n* Report using other illicit drugs in the prior 4 weeks\n* History or current evidence of severe psychiatric illness or medical condition judged by the study physician and PI to put the participant at greater risk of experiencing adverse events due to completion of study procedures, interfere with their ability to participate in the study, or their capacity to provide informed consent.\n* Current use of medical cannabis, prescription analgesics, or any medications that may affect study outcomes\n* Current pain\n* Insensitivity to the cold water stimulus of the Cold Pressor Test\n* FEMALES: using a hormonal contraceptive",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "21 Years",
            "maximumAge": "55 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Ziva Cooper, PhD",
                    "role": "CONTACT",
                    "phone": "310-206-9942",
                    "email": "zcooper@mednet.ucla.edu"
                },
                {
                    "name": "Vincent Acebo",
                    "role": "CONTACT",
                    "phone": "310-983-3417",
                    "email": "vacebo@mednet.ucla.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Ziva Cooper, PhD",
                    "affiliation": "University of California, Los Angeles",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of California, Los Angeles",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ziva Cooper, Phd",
                            "role": "CONTACT",
                            "phone": "310-206-9942",
                            "email": "zcooper@mednet.ucla.edu"
                        },
                        {
                            "name": "Vincent Acebo",
                            "role": "CONTACT",
                            "phone": "310-983-3417",
                            "email": "vacebo@mednet.ucla.edu"
                        },
                        {
                            "name": "Ziva Cooper, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000019966",
                    "term": "Substance-Related Disorders"
                }
            ],
            "ancestors": [
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5449",
                    "name": "Marijuana Abuse",
                    "relevance": "LOW"
                },
                {
                    "id": "M13066",
                    "name": "Pain",
                    "relevance": "LOW"
                },
                {
                    "id": "M21837",
                    "name": "Substance-Related Disorders",
                    "asFound": "Abuse, Drug",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}